Pharmacom Research

Research

Home

Technology Platform

4S Architecture

Core Technologies

Biopharmaceutical

Biotechnology

Biodefense

Bioinformatics

Core Technologies

The company's proprietary technology is an innovative high-throughput screening, detecting and capturing technology for chemical, biochemical and cellular agents. The core technology pools the advantages from:

nanoarray technology which allows nanoscale multi-dimensional analysis;
bioaffinity technology which detects a wide range of molecule-molecule interactions;
molecularly imprinted polymer technology which provides the potential for molecular fabrication, rearrangement and manipulation;
data mining technology which is driven by the algorithms of genomics, proteomics and molecular physicochemical properties;
sensing technology which provides the interface for target-specific microelectrochemical detection.

"SCH"

-technology of single cell handling, cellular fractioning, molecular separation, variety discrimination, and molecule sorting

"LSP"

-technology of the localization and tracing signaling pathways of molecules in living cells

"SSS"

-technology of single molecule localization, separation, identification and characterization

"MAIDS"

-technology of the microscale parallel analysis of peptides, nucleotides, small molecules, cells, bacteria, viruses, and microorgasms

"LKNMCI"

-technology of the bioaffinity-based multiarray-featured protein identification

"M-POAR"

-technology of real-time molecule collection and automatic sample handling

"DWME"

-technology of database-driven wireless-featured microprofiling system engineering

"FACS-S"

-technology of tracking molecule-molecule interaction events at single bacterium/cell level

Pharmacom Corporation